Structure-activity relationships between linkage style at the C-3 position and nuclear analogues of C(7)-hydroxyminoammothiazol cephalosporins against methicillin-resistant staphylococcus aureus

Journal of Infection and Chemotherapy

Volumn 2, Issue 3, 1996, Pages 143-147

  Hanaki, Hideaki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Cephalosporin; MRSA; Structure activity relationship

Indexed keywords

EID: 0000627225     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02351566     Document Type: Article

References (25)

1. Tomasz A. Multiple antibiotic resistance-pathogenic bacteria. New Engl J Med 1994;330:1247-1251.
2. Collins JK, Mader JY, Kelly MT. Resistance of methicillin-resistant Staphylococcus aureus to third-generation cephalosporins. J Infect Dis 1983;147:591.
3. Maple PAC, Hamilton-Miller JM, Brumfitt W.World-wide antibiotic-resistance in methicillin-resistant Staphylococcus aurens. Lancet 1989;1:537-540.
4. Shalti I, Berger SA, Gorea A, Frimerman H. Widespread quinolone resistance among methicillin-resistant Staphylococcus anreus isolates in a general hospital. Antimicrob Agents Chemother 1989;33:593-594.
5. Tonin E, Tomasz A. β-lactam-specific resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother 1986;30:577-583.
6. Utsui Y, Yokota T. Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1985;28:397-403.
7. Hartman, BJ, Tomasz A. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol 1984;158:513-516.
8. Hayes MV, Curtis NAC, Wyke AW, Ward JB. Decreased affinity of a penicillin-binding protein for beta-lactam antibiotics in a clinical isolate of Staphylococcus aureus resistant to methicillin. FEMS Lett 1981;298:133-136.
9. Murakami K, Nomura K, Doi M, Yoshida T. Production of low-affinity penicillin-binding protein by low- and high-resistance groups of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1987;31:1307-1311.
10. Sorrell TC, Packhan DR, Shanber S, Goldes M, Munro R. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982;97:344-350.
11. Foster JK, Lentino JR, Strodtman R, Vincen D. Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamycin- and methicillin-resistant Staphylococcus aureus by time-killing studies. Antimicrob Agents Chemother 1986;30:823-827.
12. Farber BE, Moellering RC Jr. Retrospective study of the toxicity of preparation of vancomycin from 1974 to 1981. Antimicrob Agents Chemother 1983;23:138-141.
13. Levine DP. Slow response to vancomycin plus rifampicin in methicillin-resistant Staphylococcus aureus. Ann Intern Med 1991;115:674-680.
14. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 1993;37:1563-1571.
15. Gutmann L, Billot-Klein D, Al-Obeid S, Klare I, Francoual S, Collatz E,Van Heijenoort J. Inducible carboxypeptidase activity in vancomycin-resistant enterococci. Antimicrob Agents Chemother 1992;36:77-80.
16. Uttley AC, Collins CH, Naidoo J, George RC. Vancomycin-resistant Enterococci. Lancet 1988;1:57-58.
17. Druckheimer W, Adam F, Fischer G, Kirrstetter R. Recent developments in the field of cephem antibiotics. In: Testa B (ed) Advances in drug research. Boca Raton FL: Academic Press, 1988:61-234.
18. Hanaki H, Akagi H, Yasui M, Otan T. Structure-activity relationships of 2-thioisocephem against methicillin-resistant Staphylococcus aureus. J Antibiot 1995;48:901-903.
19. Hanaki H, Akagi H, Yasui T, Otani T, Hyodo A, Hiramatsu K. TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1995;39:1120-1126.
20. Hanaki H, Akagi H, Shimizu C, Hyodo A, Unemi N, Yasui M, Hara Y. Active new cephalosporin, TOC-39. TOC-50, against multi-resistant MRSA. In: Program Abstracts of the 33rd Intersci Conf Antimicrob Agents Chemother, 1993 (abstr 889).
21. Hiramastu K, Asada A, Tateda-Suzuki E, Kuwahara-Arai K. TOC-39 and TOC-50, a novel class of cephalosporin having a high binding affinity to the MRSA-specific penicillin-binding protein, PBP2'. In: Program Abstracts of the 33rd Intersci Conf Antimicrob Agents Chemother, 1993 (abstr 888).
22. Lowry OH, Rosebrough NJ, Farr AJ, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
23. Spratt BG. Properties of the penicillin-binding proteins of Escherichia coli K12. Eur J Biochem 1977;72:341-352.
24. Suzuki E, Hiramatsu K, Yokota T. Survey of methicillin-resistant clinical strains of coagulase-negative Staphylococci for mecA gene distribution. Antimicrob Agents Chemother 1992;36:429-434.
25. Finney DJ. Probit Analysis. 3rd ed. London: Cambridge University Press, 1971.